SFS
MRKR icon

Sowell Financial Services’s Marker Therapeutics MRKR Stock Holding History

Sowell Financial Services’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50
Closed -$1K – 1890
2021
Q1 		$1K Hold
50
– – ﹤0.01% 2979
2020
Q4 		$1K Hold
50
– – ﹤0.01% 2596
2020
Q3 		$1K Hold
50
– – ﹤0.01% 2401
2020
Q2 		$1K Hold
50
– – ﹤0.01% 2339
2020
Q1 		$1K Hold
50
– – ﹤0.01% 2284
2019
Q4 		$1K Hold
50
– – ﹤0.01% 2379
2019
Q3 		$3K Buy
+50
New +$2.96K ﹤0.01% 1951

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sowell Financial Services's MRKR Position: Q2 2021 in Review

Sowell Financial Services sold out of Marker Therapeutics (MRKR) in Q2 2021, closing a stake of 50 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in MRKR in Q3 2019 and held it in 7 quarters. The position peaked at $3K in Q3 2019. 74 funds tracked by Wall St. Rank hold MRKR as of Q2 2021.

  • Sowell Financial Services reported no remaining Marker Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 50 Marker Therapeutics shares in Q2 2021, an estimated $1K.
  • Sowell Financial Services first reported a position in Marker Therapeutics in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Marker Therapeutics position peaked at $3K in Q3 2019.
  • 74 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.